HomeConference ChairsSteering Board Members Speakers & ModeratorsProgram Agenda

RegistrationAbstract Submission

CME

Don’t miss the opportunity to qualify for e-Poster presentations.

Submit Abstract Now

Deadline for submission is November 25th

The Scientific Committee will review all submitted abstracts. Notification regarding abstract acceptance will be sent to the submitting author via e-mail. All notifications of schedule and correspondence will be directed to the submitting author via email. 

Eligibility Requirements

  • To qualify for e-Poster presentations, kindly submit your abstract on or before November 25th.
  • Selected candidates must register and pay the registration fees.
  • Abstracts must be written in English.
  • The Scientific Organizing Committee will review all submissions.
  • Abstract content must be unpublished material.
  • Submission of an abstract constitutes a commitment by the author (s) to prepare a 2-minutes recorded presentation.

Review Process

Abstracts will be scored on the following criteria:

  • Scientific merit
  • Selection and submission to PMFG21 themes, kindly indicate which theme your abstract falls under:
    • Future of Pediatric Genomic Medicine
    • Large Scale Genomes and Data: From Discovery to Health 
    • Precision Care in Maternal and Child Health
    • Advances in Innovative Therapies for Precision Medicine
  • Originality of work
  • Adequate sample size and statistics
  • Clarity, punctuation, and grammar

How to Apply

  • Review the guidelines for submission.
  • Indicate which theme your abstract falls under (1-4)
  • Abstracts can only be submitted online via email to PMFG@sidra.org

Acceptance

The Scientific Committee will review all submitted abstracts. Notification regarding abstract acceptance will be sent to the submitting author via e-mail. All notifications of schedule and correspondence will be directed to the submitting author via email.

Abstract Structure

  • Title - should be written in sentence structure (capitalize the first word and remaining words begin in lower case).
  • Author names - should begin on the line immediately after the Title. If there are multiple authors underline the name of the presenting author. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Also indicate in superscript who will be the presenting and corresponding author with * and #, respectively.

    For example: First name, Last name*, First name, Last name# a department name, Institution, City, Country b Department name, Institution, City, Country * Presenting author # Corresponding author

    Note: Title, authors’ names and affiliations must be positioned at the top center of the abstract. Leave single line space between the affiliation address(es) and the beginning of the abstract paragraph
     
  • The abstract cannot exceed 300 words written in single-space.
  • State the study's research objective and rationale, summarize methods and results, and state the conclusions.
  • Abstracts must be data-driven and must include this information in the body of the abstract.
  • All abbreviations should be defined when first used.

 

PMFG21 Partners

qatarbiobank weill qatar cancer society Qu
qatar genome HBKU HMC